Lars Johansson Selected Research

Liver Cirrhosis (Hepatic Cirrhosis)

10/2020

Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Johansson Research Topics

Disease

17	Type 2 Diabetes Mellitus (MODY) 12/2023 - 12/2008
16	Body Weight (Weight, Body) 12/2023 - 10/2002
12	Neoplasms (Cancer) 02/2024 - 09/2003
9	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2018
9	Myocardial Infarction 02/2017 - 01/2002
8	Stroke (Strokes) 03/2021 - 08/2005
7	Obesity 12/2023 - 04/2004
7	Hemorrhage 12/2016 - 06/2007
5	Cerebral Hemorrhage 11/2020 - 04/2004
5	Ischemic Stroke 01/2017 - 08/2005
4	Inflammation (Inflammations) 12/2023 - 12/2008
4	Cicatrix (Scar) 02/2017 - 07/2009
3	Fibrosis (Cirrhosis) 12/2023 - 01/2022
3	Overweight 12/2023 - 11/2018
3	Weight Loss (Weight Reduction) 01/2022 - 01/2011
3	Fatty Liver 11/2021 - 12/2019
3	Hypertension (High Blood Pressure) 01/2020 - 01/2017
3	Insulin Resistance 01/2019 - 12/2008
3	Hemorrhagic Stroke 01/2017 - 02/2002
3	Atrial Fibrillation 12/2016 - 10/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 01/2010
3	Myocardial Ischemia (Ischemic Heart Diseases) 08/2004 - 08/2002
2	Chronic Renal Insufficiency 12/2023 - 10/2009
2	Abdominal Obesity 01/2023 - 05/2012
2	Heart Failure 01/2019 - 05/2011
2	Infarction (Infarctions) 03/2017 - 02/2015
2	Infections 03/2016 - 03/2012
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016 - 05/2012
2	Death (Near-Death Experience) 01/2016 - 05/2013
2	Insulinoma 07/2014 - 05/2014
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2014 - 01/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2014 - 05/2008
2	Atherosclerosis 12/2012 - 10/2007
2	Coronary Disease (Coronary Heart Disease) 10/2007 - 03/2006
2	Coronary Occlusion 07/2006 - 08/2004
1	Thyroid Neoplasms (Thyroid Cancer) 02/2024
1	Alcoholic Fatty Liver 12/2023
1	Albuminuria 01/2023

Drug/Important Bio-Agent (IBA)

10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2012
7	dapagliflozinIBA 01/2023 - 03/2012
7	AnticoagulantsIBA 01/2017 - 07/2009
6	EnzymesIBA 11/2021 - 12/2012
6	Warfarin (Coumadin)FDA LinkGeneric 12/2016 - 06/2007
5	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2023 - 05/2014
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2014
5	von Willebrand FactorIBA 11/2020 - 02/2002
5	Blood Glucose (Blood Sugar)IBA 03/2017 - 06/2010
4	LipidsIBA 12/2023 - 01/2015
4	Dihydroorotate DehydrogenaseIBA 08/2023 - 01/2018
4	Exenatide (Byetta)FDA Link 01/2023 - 05/2014
4	Protons (Proton)IBA 01/2022 - 04/2020
4	Glucagon-Like Peptide-1 ReceptorIBA 01/2021 - 05/2014
4	CholesterolIBA 01/2018 - 06/2014
4	GadoliniumIBA 02/2017 - 07/2006
4	Tryptophan (L-Tryptophan)FDA Link 01/2017 - 05/2014
4	C-Reactive ProteinIBA 02/2015 - 10/2007
4	Contrast MediaIBA 07/2006 - 10/2002
3	Glucagon Receptors (Glucagon Receptor)IBA 12/2023 - 10/2020
3	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 03/2012
3	Triglycerides (Triacylglycerol)IBA 04/2020 - 12/2012
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019 - 03/2012
3	Insulin (Novolin)FDA Link 12/2018 - 06/2010
3	AntigensIBA 11/2015 - 07/2009
3	Troponin IIBA 02/2015 - 05/2011
3	manganese chloride (manganese chloride, tetrahydrate)FDA Link 04/2014 - 05/2004
3	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2012 - 01/2002
3	ThrombomodulinIBA 07/2009 - 02/2002
3	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 08/2004 - 10/2002
2	CreatinineIBA 01/2023 - 08/2013
2	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2020
2	glimepiride (Amarel)FDA LinkGeneric 01/2022 - 01/2020
2	saxagliptin FDA Link 01/2022 - 01/2020
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2021 - 07/2014
2	Factor XII (Hageman Factor)IBA 03/2021 - 01/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2019 - 03/2006
2	Sodium-Glucose Transport ProteinsIBA 01/2019 - 03/2012
2	Carboxylic AcidsIBA 11/2018 - 01/2018
2	fibrin fragment D (D-dimer)IBA 01/2018 - 05/2014
2	LDL CholesterolIBA 03/2017 - 06/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2017 - 12/2012
2	omega-Chloroacetophenone (Mace)IBA 01/2016 - 05/2013
2	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2015 - 05/2011
2	pro-brain natriuretic peptide (1-76)IBA 02/2015 - 05/2011
2	Cystatin CIBA 02/2015 - 08/2013
2	Parathyroid Hormone (Parathormone)IBA 11/2014 - 07/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2014 - 01/2007
2	N,N'- bis(pyridoxal- 5- phosphate)ethylenediamine- N,N'- diacetic acid (mangafodipir)FDA Link 04/2014 - 05/2004
2	Plasminogen Activators (Plasminogen Activator)IBA 12/2012 - 08/2005
2	Lipoproteins (Lipoprotein)IBA 12/2012 - 05/2012
2	IronIBA 01/2007 - 10/2002
1	RacivirIBA 02/2024
1	Liraglutide FDA Link 12/2023
1	cotadutideIBA 12/2023
1	AlbuminsIBA 01/2023
1	LithiumIBA 01/2023
1	gastric inhibitory polypeptide receptorIBA 12/2022

Therapy/Procedure

4	Therapeutics 10/2020 - 01/2018
3	Drug Therapy (Chemotherapy) 12/2023 - 09/2003
3	Glycemic Control 01/2022 - 03/2012
1	Thyroidectomy 02/2024